Valuations that separate the goodwill that transfers from the goodwill that walks out the door.

A specialist medical or diagnostic imaging practice valuation separates transferable enterprise value — rooms, staff, equipment, contracts and institutional referral flows — from the personal goodwill that exits with the practitioner. Prismi prepares evidence-led valuations for practice sales, associate buy-ins, consolidator offers, restructures and CGT matters, testing referral transferability, Medicare licensing and accreditation overlays and contractor payroll tax exposure, and concluding at the most supportable position within a defensible range.

When a specialist or imaging practice needs a formal valuation

Specialist and imaging valuations are commissioned around ownership and tax events: a sale or an approach from a corporate acquirer, an associate buying in or a principal retiring out, a transfer of the practice or its service entity between family entities, or a restructure of the group. Related-party transfers engage the market value substitution rule in s 116-30 ITAA 1997; exits engage the Division 152 small business CGT concessions, where the s 152-40 active asset test and the maximum net asset value test both turn on supportable market values; restructures may rely on the Subdivision 328-G rollover; and loans running between practice, service and investment entities can raise Division 7A questions that need market value evidence underneath them. Family law settlements involving a specialist practice raise the personal-goodwill question in its sharpest form. Prismi prepares the valuation with ATO market valuation expectations in mind — consistent with IVS 104 and APES 225, on the willing-but-not-anxious basis from Spencer v Commonwealth — with fees fixed at engagement and never contingent on the outcome, every report senior-reviewer signed with a formal independence statement, and the working file retained for ten years. We are not a registered tax agent and do not provide tax, legal or financial advice; your accountant or lawyer applies the outcome.

Personal versus transferable goodwill in referral-driven practices

In a specialist medical practice valuation, goodwill splits into two kinds: transferable goodwill, which survives a sale because it attaches to the practice, and personal goodwill, which attaches to the individual practitioner and exits with them. Transferable value shows up as rooms, trained staff, fitted-out procedure or imaging suites, accreditations, contracts, and referral relationships that are institutional (a GP clinic that refers to the practice or the co-located imaging brand, whatever the roster) rather than personal (a GP who refers to one surgeon by name). No informed buyer pays for personal goodwill, whatever the historical profit and loss says. The working file evidences the split rather than asserting it: billings by referring practitioner, top-ten referrer concentration and tenure, the share of referrals naming the individual versus the practice, rebooking and recall rates, and associate depth — whether patients and referrers have already demonstrated they will see someone else. Succession risk is priced the same way: a practice with credentialled associates, documented handover protocols and a principal willing to work a transition period under a restraint supports a materially stronger position than one where the referral base has only ever known one name. Diagnostic imaging sits further toward the transferable end — referrals typically flow to location, equipment and reporting turnaround rather than to an individual radiologist — which is precisely why imaging attracts corporate capital while many procedural specialties do not.

Diagnostic imaging: LSPN, DIAS accreditation and capital sensitivity

Imaging carries a regulatory overlay general practice never sees, and each layer is a valuation input. Every site billing Medicare for diagnostic imaging must hold a Location Specific Practice Number registered with Services Australia and quoted on each claim, and must be accredited under the Diagnostic Imaging Accreditation Scheme — practices accredited at entry level currently have two years to achieve the full suite of standards. Capital sensitivity ties Medicare benefits to equipment age: since 1 May 2020, benefits are not payable for services rendered on equipment that has exceeded its effective life age or maximum extended life unless an exemption applies. The valuation therefore audits the equipment register — installation dates, upgrade history, remaining effective life — and carries the replacement capital expenditure needed to keep billing into maintainable earnings, not merely historical depreciation. MRI eligibility is the moving part: licensing was deregulated in Modified Monash 2–7 areas from 1 November 2022, equipment-based licences were replaced with practice-based eligibility from 1 July 2025 (converting partial and previously ineligible units at licensed practices to full eligibility), and under announced settings metropolitan comprehensive practices become eligible from 1 July 2027. A Medicare MRI licence that once traded at a scarcity premium is a diminishing asset, and a supportable valuation prices the cash flows under current and announced settings rather than capitalising scarcity that is being legislated away. These settings move; the report documents the rules as at the valuation date.

Service entities and payroll tax on contractor practitioners

Most specialist and imaging groups run a service entity that collects patient or Medicare receipts and remits a percentage to practitioners engaged as contractors. The line of authority running through Commissioner of State Revenue v The Optical Superstore and Thomas and Naaz v Chief Commissioner of State Revenue, followed by broadly harmonised revenue office rulings in New South Wales, Victoria, Queensland and South Australia, treats many of these arrangements as relevant contracts — with the amounts flowing to practitioners deemed wages for payroll tax. The relief that followed has been aimed squarely at general practice: the amnesties and the exemptions tied to bulk-billed GP services in several states generally do not extend to specialists, radiologists or imaging practices. For valuation purposes the exposure lands twice. Any unremediated historical liability is a contingent claim against the entity being valued, and the go-forward payroll tax cost belongs in maintainable earnings whether or not an assessment has issued, because an informed purchaser will price it in. The working file records the contractual flow of funds, the jurisdictions involved and the payroll tax treatment assumed — flagged for the client's advisers, because whether and how the arrangements can be restructured is tax and legal advice Prismi does not give. What we do is make sure the number does not silently assume the exposure away.

Consolidator appetite and the multiple it moves

Diagnostic imaging is among the most actively consolidated sectors in Australian health care: Integral Diagnostics completed its merger with Capitol Health in December 2024 after ACCC clearance subject to a divestiture, I-MED has traded under private-equity ownership with sale processes periodically reported, and listed and private-equity-backed groups continue to acquire in radiology, ophthalmology, oncology and day-procedure specialties. Consolidators pay materially higher multiples than private buyers — but only for practices that fit a platform: multi-practitioner rosters, associate depth beyond the principals, corporatised management, clean DIAS accreditation and equipment registers, and earnings that survive practitioner remuneration restated to market and payroll tax normalisation. A single-principal practice whose referrals follow one name cannot access that market, and the most common way these valuations fail is by importing a consolidator multiple into a practice no consolidator would buy. The Prismi report makes market access an explicit, evidenced finding and selects the multiple from the market the practice can actually reach — noting that consolidator appetite moves with debt markets and platform strategy, so a headline transaction multiple is evidence, not an entitlement.

What the valuation file needs from a specialist or imaging practice

• ·Financial statements and tax returns for the practice, service and any equipment or freehold entities (three to five years)
• ·Billing analysis by item number and by practitioner, including the bulk-billed versus privately billed split
• ·Referral data: billings by referring practitioner, top-ten referrer share and tenure, and whether referrals name the individual or the practice
• ·LSPN registration details and current DIAS accreditation certificates for each site
• ·Equipment register with installation dates, upgrade history and capital sensitivity status, plus committed capital expenditure
• ·Practitioner service or contractor agreements, the documented flow of funds, restraints, and any payroll tax advice or assessments received
• ·Hospital or day-surgery accreditations, session arrangements and on-call obligations
• ·Premises leases or related-party rent arrangements, for restatement to market where required
• ·Partnership, unitholder or shareholder agreements, including pre-emptive rights and valuation clauses

Which Prismi tier fits a specialist or imaging valuation

Most specialist and imaging engagements are Comprehensive (from $3,995 + GST, 15–25 business days): associate buy-ins, partner exits, related-party transfers and pre-sale positions where the parties need full methodology, the goodwill split reasoned and the licensing overlay documented. The Defensible Valuation File (from $8,995 + GST, 25–35 business days) is the right tier where the number will be tested — negotiating against a consolidator, small business CGT concession claims that may face ATO review, contested exits and family law matters — because it documents the referral analysis, payroll tax normalisation and equipment findings at working-paper depth, with the working file retained for ten years. Essential (from $1,495 + GST, 10–14 business days) suits early indicative planning only; the personal-goodwill question usually justifies the deeper tiers. Where advisers need alternatives modelled explicitly — a consolidator offer against continued ownership, or earnings under different payroll tax and MRI-eligibility assumptions — the Valuation Range & Scenario Review (from $12,995 + GST, 30–45 business days) is built for exactly that. Retrospective valuations are +$495 per historical date, additional entities are +$750 each — almost always relevant where practice, service and equipment entities sit side by side — and rush delivery is +30%, subject to capacity. Fees are fixed at engagement and never contingent on the outcome. If an engagement requires a predetermined number rather than a supportable one, we will say so and decline the engagement on those terms.